Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (FY)Mar 31, 2025 | (FY)Mar 31, 2024 | (FY)Mar 31, 2023 | |
|---|---|---|---|
| Total revenue | 32.37%13.1B | 41.95%9.9B | 6.97B |
| Cost of revenue | 46.61%6.61B | 97.58%4.51B | 2.28B |
| Gross profit | 20.47%6.49B | 14.90%5.39B | 4.69B |
| Operating expense | 25.61%3.83B | 16.78%3.05B | 2.61B |
| Operating profit | 13.77%2.66B | 12.55%2.34B | 2.08B |
| Net non-operating interest income (expenses) | 7,862.50%4.46M | 105.96%56K | -939K |
| Non-operating interest income | 7,862.50%4.46M | 1.82%56K | --55K |
| Non-operating interest expense | ---- | --0 | --994K |
| Net investment income | -335.93%-26.66M | 23.50%-6.12M | -7.99M |
| Gain(Loss) on financial instruments designated as cash flow hedges | |||
| Gain(Loss) on derecognition of available-for-sale financial assets | -10.2M | 0 | |
| Income from associates and other participating interests | |||
| Special income (charges) | 29.09%-273K | 99.80%-385K | -196.79M |
| Less:Other special charges | -29.09%273K | -99.80%385K | --196.79M |
| Other non-operating income (expenses) | -156.51%-23.02M | -274.61%-8.98M | 5.14M |
| Income before tax | 12.13%2.61B | 23.74%2.33B | 1.88B |
| Income tax | 8.66%915.44M | 49.53%842.47M | 563.42M |
| Net income | 14.10%1.69B | 12.70%1.48B | 1.32B |
| Net income continuous operations | 14.10%1.69B | 12.70%1.48B | --1.32B |
| Noncontrolling interests | |||
| Net income attributable to the company | 14.10%1.69B | 12.70%1.48B | 1.32B |
| Preferred stock dividends | |||
| Other under preferred stock dividend | 0 | 0 | 0 |
| Net income attributable to common stockholders | 14.10%1.69B | 12.70%1.48B | 1.32B |
| Gross dividend payment | |||
| Basic earnings per share | 14.08%40.94 | 12.70%35.8856 | 31.8415 |
| Diluted earnings per share | 5.61%37.9 | 12.70%35.8856 | 31.8415 |
| Dividend per share | |||
| Currency Unit | JPY | JPY | JPY |
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |